Endotype-driven treatment in chronic upper airway diseases
Abstract Rhinitis and rhinosinusitis are the two major clinical entities of chronic upper airway disease. Chronic rhinosinusitis (CRS) and allergic rhinitis (AR) affect respectively up to 10 and 30% of the total population, hence being associated with an important socio-economic burden. Different ph...
Main Authors: | Glynnis De Greve, Peter W. Hellings, Wytske J. Fokkens, Benoit Pugin, Brecht Steelant, Sven F. Seys |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2017-07-01
|
Series: | Clinical and Translational Allergy |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s13601-017-0157-8 |
Similar Items
-
EUFOREA Rhinology Research Forum 2017: report of the brainstorming sessions on endotype-driven treatment, patient empowerment and digital future in airways care
by: Valerie J. Lund, et al.
Published: (2018-03-01) -
Upper airway obstruction in rhinitis and rhinosinusitis
by: Jitka Vydrová
Published: (2020-07-01) -
Visual analogue scale for sino-nasal symptoms severity correlates with sino-nasal outcome test 22: paving the way for a simple outcome tool of CRS burden
by: Maria Doulaptsi, et al.
Published: (2018-09-01) -
Benefits and harm of systemic steroids for short- and long-term use in rhinitis and rhinosinusitis: an EAACI position paper
by: Valerie Hox, et al.
Published: (2020-01-01) -
Endotyping of Chronic Rhinosinusitis With and Without Polyp Using Transcription Factor Analysis
by: Pongsakorn Tantilipikorn, et al.
Published: (2018-03-01)